Senior Patient Access Lead

The Patient Access (PA) Lead ensures access of brands to the patients, influencing and developing health political legislation and regulations, national and regional reimbursement and listings. Accounts for optimal prices of launch and in-market brands. Ensures also proactive maintenance of brands already on the market, in terms of pricing and overall expenditures restrictions and generic threats. Leverages on a deep understanding of the Country political environment and healthcare structure, of national and regional regulations and drug lists to devise innovative PA initiatives that will guarantee a sustainable competitive advantage in a given business environment. Able to contribute to the regulatory decision-making process and policy environment. Acts as advisor to the LT in directing allocations of resources and investments across functions for products/customer segments in accordance with best ROI outcomes.

Major Accountabilities:

Responsible for the development of Health Policy Operations/Pricing and Health Policy Operations/Reimbursement & Listing: Ensure best launch and in-market prices according to the market situation, aligned with LT decisions and global strategies; ensure accurate qualitative and quantitative input into Budget and Strategic Planning. Facilitate and consolidate country input on Regional and Global strategy development. Contribute with an understanding of the impact on business strategy caused by competitors’ actions.
• Responsible for the Health Policy Operations / Reimbursement & Listing: Ensure listing in regional and national drug lists; ensure HTA evaluations (as applicable) according to target positioning and reimbursement aligned with CPO and brand strategy. Influence early decisions in global and local development program regarding understanding of competitive environment and requirements from country and local HA’s in order to facilitate market access.
• Responsible for influencing the National Health Policy: Ability to see and communicate connections in available information and how they may translate into scenarios with commercial significance. Proactively influence the pharma political environment through continuous lobbying and cooperation with the industry association
• Responsible for the development of tools and processes to evaluate return on investment of Market Access activities: Understanding the company portfolio; MA needs and contributions. Direct allocation of resources to achieve superior company business results.
• Responsible for understanding and communicating customer insights to recognize business opportunities: Building alliances and networks to capture customer insights. Lead the establishment of cross-functional teams to optimize business logic and commercial outcomes.
• Observe strictly any and all applicable internal and external regulations, acts and procedures, including, but not limited to: Internal Rules, Code of Conduct, Corporate Citizenship, P3, local industry code, etc.
• Responsible for proper and compliant reporting of Adverse Events and technical complaints in order to fulfill all regulatory requirements and ethical obligations including timely forwarding of all spontaneous reports to local Drug Safety Responsible.
• Comply with the GxP quality requirements applicable to his/her area of responsibility, incl. but not limited to proper reporting of adverse events and customer complaints, samples handling as well as any incident that may adversely affect the quality, safety, identity, strength, purity, availability or efficacy of a commercial product or clinical trial material and/or may compromise the Novartis Quality System and the global Novartis reputation
• On time reporting of spontaneous adverse events (AE) reports and technical complaints for all Novartis products